Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3

Status

Completed 5Terminated 4Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Sarcoma 1Lung Neoplasms 1Glioma 1Glioblastoma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × fluoromisonidazole × Clear all
NCT03303469 2021-02-21

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

University of Alabama at Birmingham

Phase 2 Terminated
3 enrolled 4 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01868906 2018-08-24

FMISOPETSCS

Dr. Negrin University Hospital

Phase 2 Terminated
6 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT01169350 2017-11-17

18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Terminated
8 enrolled 4 charts
Sarcoma

Sarcoma

NCT00544674 2012-12-10

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Proacta, Incorporated

Phase 2 Terminated
5 enrolled 7 charts
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡